VaxArray rapid response to seasonal strain changes for influenza vaccines

(InDevR, Inc.) InDevR expanded its license agreement with the Technology Transfer Program at the US Food and Drug Administration (FDA) to address strain changes recommended by the World Health Organization (WHO) for 2018/2019 seasonal influenza vaccines. The new VaxArray ® Influenza Seasonal HA reagent kit (v2.0) has improved sensitivity to the latest A/H3N2 and B/Victoria-like viruses. Version 2.0 of the potency test is available now for evaluation and will be available for purchase by April 21, 2018.
Source: EurekAlert! - Biology - Category: Biology Source Type: news